Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.
4.

Publication bias on clinical studies of pharmacokinetic interactions between felodipine and grapefruit juice.

Uesawa Y, Takeuchi T, Mohri K.

Pharmazie. 2010 May;65(5):375-8. Review.

PMID:
20503932
5.

Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model.

Takanaga H, Ohnishi A, Matsuo H, Murakami H, Sata H, Kuroda K, Urae A, Higuchi S, Sawada Y.

Br J Clin Pharmacol. 2000 Jan;49(1):49-58.

6.

Effect of grapefruit juice on the disposition of manidipine enantiomers in healthy subjects.

Uno T, Ohkubo T, Motomura S, Sugawara K.

Br J Clin Pharmacol. 2006 May;61(5):533-7.

7.

Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.

Bailey DG, Dresser GK, Bend JR.

Clin Pharmacol Ther. 2003 Jun;73(6):529-37.

PMID:
12811362
8.

Interaction of citrus juices with pranidipine, a new 1,4-dihydropyridine calcium antagonist, in healthy subjects.

Hashimoto K, Shirafuji T, Sekino H, Matsuoka O, Sekino H, Onnagawa O, Okamoto T, Kudo S, Azuma J.

Eur J Clin Pharmacol. 1998 Nov-Dec;54(9-10):753-60.

PMID:
9923580
9.

Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice.

Veronese ML, Gillen LP, Burke JP, Dorval EP, Hauck WW, Pequignot E, Waldman SA, Greenberg HE.

J Clin Pharmacol. 2003 Aug;43(8):831-9.

PMID:
12953340
11.

Effect of grapefruit juice in relation to human pharmacokinetic study.

Uno T, Yasui-Furukori N.

Curr Clin Pharmacol. 2006 May;1(2):157-61. Review.

PMID:
18666368
12.

A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction.

Paine MF, Widmer WW, Hart HL, Pusek SN, Beavers KL, Criss AB, Brown SS, Thomas BF, Watkins PB.

Am J Clin Nutr. 2006 May;83(5):1097-105. Erratum in: Am J Clin Nutr. 2006 Jul;84(1):264.

13.

Coadministration of grapefruit juice increases systemic exposure of diltiazem in healthy volunteers.

Christensen H, Asberg A, Holmboe AB, Berg KJ.

Eur J Clin Pharmacol. 2002 Nov;58(8):515-20. Epub 2002 Oct 16.

PMID:
12451428
14.

Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.

Katoh M, Nakajima M, Shimada N, Yamazaki H, Yokoi T.

Eur J Clin Pharmacol. 2000 Feb-Mar;55(11-12):843-52.

PMID:
10805063
15.

Interaction of grapefruit juice and calcium channel blockers.

Sica DA.

Am J Hypertens. 2006 Jul;19(7):768-73. Review.

PMID:
16814135
16.

Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine.

Paine MF, Widmer WW, Pusek SN, Beavers KL, Criss AB, Snyder J, Watkins PB.

Am J Clin Nutr. 2008 Apr;87(4):863-71.

17.

Examining sex-related differences in enteric itraconazole metabolism in healthy adults using grapefruit juice.

Gubbins PO, Gurley BJ, Williams DK, Penzak SR, McConnell SA, Franks AM, Saccente M.

Eur J Clin Pharmacol. 2008 Mar;64(3):293-301. doi: 10.1007/s00228-007-0417-y. Epub 2008 Jan 3.

PMID:
18172627
18.

Predictive performance of three practical approaches for grapefruit juice-induced 2-fold or greater increases in AUC of concomitantly administered drugs.

Takahashi M, Onozawa S, Ogawa R, Uesawa Y, Echizen H.

J Clin Pharm Ther. 2015 Feb;40(1):91-7. doi: 10.1111/jcpt.12231. Epub 2014 Nov 4.

PMID:
25365914
19.

Evaluation of the inhibitory effect of dihydropyridines on N-type calcium channel by virtual three-dimensional pharmacophore modeling.

Ogihara T, Kano T, Kakinuma C.

Arzneimittelforschung. 2009;59(6):283-8. doi: 10.1055/s-0031-1296398.

PMID:
19634509
20.

Grapefruit juice increases oral nimodipine bioavailability.

Fuhr U, Maier-Brüggemann A, Blume H, Mück W, Unger S, Kuhlmann J, Huschka C, Zaigler M, Rietbrock S, Staib AH.

Int J Clin Pharmacol Ther. 1998 Mar;36(3):126-32.

PMID:
9562227

Supplemental Content

Support Center